SEARCH RESULTS FOR: ("hf acquisition co")(443834 results)

Export results
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Filters
Sort By
10
Results Per Page
10
Results/Pg
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

iTero Element 5D Plus Ready US Cart configuration - 00816063020806

Scanner, cart configuration
Align Technology, Inc.
211898
In Commercial Distribution

  • 00816063020806 ()


  • Dental milling system, CAD/CAM, chairside

iTero Element 2 Plus upgrade mobile configuration - 00816063020769

Scanner, mobile configuration
Align Technology, Inc.
211372
In Commercial Distribution

  • 00816063020769 ()


  • Dental milling system, CAD/CAM, chairside

iTero Element 5D Plus mobile configuration - 00816063020745

Scanner, mobile configuration
Align Technology, Inc.
211491
In Commercial Distribution

  • 00816063020745 ()


  • Dental milling system, CAD/CAM, chairside

iTero Element 2 - 00816063020288

No Description
Align Technology, Inc.
202965
In Commercial Distribution

  • 00816063020288 ()


  • Dental milling system, CAD/CAM, chairside

PeriWatch Vigilance® Cues™ - B087PATT21011

PeriWatch Vigilance Cues is intended for use as an adjunct to qualified clinical decision-making during antepartum or intrapartum obstetrical monitoring at >=36 weeks gestation to obtain annotation of the FHR for baseline, accelerations and decelerations.
PERIGEN SOLUTIONS LTD
21.01.xx
In Commercial Distribution

  • B087PATT21011 ()


  • Obstetrical monitoring/analysis software

PeriWatch Vigilance® Cues™ - B087PATT202411

PeriWatch Vigilance Cues is intended for use as an adjunct to qualified clinical decision-making during antepartum or intrapartum obstetrical monitoring at >=36 weeks gestation to obtain annotation of the FHR for baseline, accelerations and decelerations.
PERIGEN SOLUTIONS LTD
2024.1.xxx
In Commercial Distribution

  • B087PATT202411 ()


  • Obstetrical monitoring/analysis software

PeriWatch Vigilance® Cues™ - B087PATT202221

PeriWatch Vigilance Cues is intended for use as an adjunct to qualified clinical decision-making during antepartum or intrapartum obstetrical monitoring at >=36 weeks gestation to obtain annotation of the FHR for baseline, accelerations and decelerations.
PERIGEN SOLUTIONS LTD
2022.2.xxx
In Commercial Distribution

  • B087PATT202221 ()


  • Obstetrical monitoring/analysis software

PeriWatch Vigilance® Cues™ - B087PATT02121

PeriWatch Vigilance Cues is intended for use as an adjunct to qualified clinical decision-making during antepartum or intrapartum obstetrical monitoring at >=36 weeks gestation to obtain annotation of the FHR for baseline, accelerations and decelerations.
PERIGEN SOLUTIONS LTD
02.12.xx
In Commercial Distribution

  • B087PATT02121 ()


  • Obstetrical monitoring/analysis software

PeriWatch™ Vigilance™ Cues™ - B087PATT02101

PeriWatch™ Vigilance™ Cues™ is intended for use as an adjunct to qualified clinical decision-making during antepartum or intrapartum obstetrical monitoring at ≥36 weeks gestation to obtain annotation of the FHR for baseline, accelerations and decelerations.
PERIGEN SOLUTIONS LTD
02.10.xx
In Commercial Distribution

  • B087PATT02101 ()


  • Obstetrical monitoring/analysis software

PeriWatch™ Cues™ - B087PATT02081

PeriWatch™ Cues™ is intended for use as an adjunct to qualified clinical decision-making during antepartum or intrapartum obstetrical monitoring at >36 weeks gestation to obtain annotation of the FHR for baseline, accelerations and decelerations.
PERIGEN SOLUTIONS LTD
02.08.xx
In Commercial Distribution

  • B087PATT02081 ()


  • Obstetrical monitoring/analysis software
< 1 ... 280 281 282 283 284 ... 1000 >